Zealand Pharma A/S (ZLDPF)
40.00
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Zealand Pharma EPS Diluted (Quarterly) : 8.610 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.610 |
| March 31, 2026 | -0.8738 |
| December 31, 2025 | -0.8368 |
| September 30, 2025 | -0.9003 |
| June 30, 2025 | 16.04 |
| March 31, 2025 | -0.6692 |
| December 31, 2024 | -0.5891 |
| September 30, 2024 | -0.5552 |
| June 30, 2024 | -0.674 |
| March 31, 2024 | -0.5401 |
| December 31, 2023 | -0.654 |
| September 30, 2023 | 0.1795 |
| June 30, 2023 | -0.8035 |
| March 31, 2023 | -0.5391 |
| December 31, 2022 | -0.8839 |
| September 30, 2022 | -0.4441 |
| June 30, 2022 | -1.288 |
| March 31, 2022 | -0.3316 |
| December 31, 2021 | -0.7494 |
| September 30, 2021 | -0.5195 |
| June 30, 2021 | -1.115 |
| March 31, 2021 | -0.935 |
| December 31, 2020 | -1.534 |
| September 30, 2020 | -0.9042 |
| June 30, 2020 | -0.2312 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.7342 |
| December 31, 2019 | -0.7974 |
| September 30, 2019 | -0.5128 |
| June 30, 2019 | -0.652 |
| March 31, 2019 | -0.6289 |
| December 31, 2018 | -0.6121 |
| September 30, 2018 | 4.354 |
| June 30, 2018 | -0.5749 |
| March 31, 2018 | -0.5236 |
| December 31, 2017 | -0.579 |
| September 30, 2017 | -0.2389 |
| June 30, 2017 | -0.5459 |
| March 31, 2017 | -0.1476 |
| December 31, 2016 | 0.2984 |
| September 30, 2016 | -0.1934 |
| June 30, 2016 | -0.6224 |
| March 31, 2016 | -0.4832 |
| December 31, 2015 | 0.4196 |
| September 30, 2015 | -0.3322 |
| June 30, 2015 | -0.4966 |
| March 31, 2015 | -0.3697 |
| December 31, 2014 | -0.4666 |
| September 30, 2014 | 0.1316 |
| June 30, 2014 | -0.3877 |
| March 31, 2014 | 0.2332 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Genmab A/S | 0.4903 |
| Ascendis Pharma A/S | 3.522 |
| Bavarian Nordic A/S | 0.4995 |
| Evaxion AS | -0.4464 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 609.41M |
| Revenue (Quarterly) | 698.72M |
| Total Expenses (Quarterly) | 89.30M |
| Enterprise Value | 644.22M |
| Gross Profit Margin (Quarterly) | 99.76% |
| Profit Margin (Quarterly) | 87.22% |
| Earnings Yield | 15.00% |
| Operating Earnings Yield | 12.90% |
| Normalized Earnings Yield | 15.12 |